Work

Clinical scale labeling of T cell immunotherapy for MRI cell tracking

Year: 2015

Type: article

Abstract: Meeting abstracts Leukocyte immunotherapies have made a great progress and hold much promise in the treatment of cancer. Specifically, in the case of B cell malignancies (such as Acute Lymphoblastic Leukemia, or ALL), CAR (chimeric antigen receptor) and TCR (T cell receptor) cell therapies have

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-3-s2-p389

Authors: Brooke M Helfer, William Shingleton, Shannon Eaker, Charles O'Hanlon, Eric Ahrens

Institutions: Celsense (United States), University of California San Diego

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490